The Gold Standard In Dietary Supplement Certification
BSCG Certified Drug Free

Home > First Reporting A Designer Steroid Norbolethone

sidebar-contact-img

Certified Drug Free®

Search According to Lot Number

Subscription to News and Blog

FIRST REPORTING OF A DESIGNER STEROID, NORBOLETHONE

DR. CATLIN WAS FIRST TO REPORT A DESIGNER STEROID, NORBOLETHONE

In 2002, Dr. Catlin was the first to report the use of a designer anabolic steroid in sport. He identified norbolethone (or norboletone) for the first time in an athlete’s urine sample. Norbolethone had been developed in the 1960s as a treatment for growth and weight gain but was deemed harmful and never brought to market. Patrick Arnold and Victor Conte introduced it to athletes through the Bay Area Laboratory Co-operative (BALCO). Dr. Catlin’s discovery of the substance was a wake-up call that some athletes were abusing designer steroids. The Chicago Tribune named Catlin Sportsman of the Year for 2002.

More Info

More about norbolethone and Dr. Catlin’s original test can be found on PubChem, a website of the U.S. National Library of Medicine: https://pubchem.ncbi.nlm.nih.gov/compound/norbolethone#section=Top

Academic Publication

Catlin DH, Ahrens BD, Kucherova Y. Detection of norbolethone, an anabolic steroid never marketed, in athletes’ urine. Rapid Communications in Mass Spectrometry 2002. 16:1273-5.

BSCG CERTIFIED CLIENTS

Twitter

facebook

The Catlin Perspective

Address
11301 W. Olympic Blvd. Suite 685 Los Angeles, CA 90064

Marketing E-mail
info@bscg.org